Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04511013
Title A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Southwest Oncology Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST